Literature DB >> 7981201

Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A.

T Crabbe1, J P O'Connell, B J Smith, A J Docherty.   

Abstract

Gelatinase A, a member of the matrix metalloproteinase (MMP) family, is secreted possessing an 80 amino acid N-terminal propeptide that must be removed in order to generate the active enzyme. Purified progelatinase A was activated to 38% of maximum by a 6 h incubation at 37 degrees C with equimolar concentrations of trypsin-activated interstitial collagenase (another MMP). The increase in activity was accompanied by cleavage of the M(r) 72,000 progelatinase A to the M(r) 66,000 active enzyme that has Y81 as its N-terminus. At low concentrations, progelatinase A was processed via an inactive intermediate, suggesting that its activation is a biphasic process. This was confirmed by the action of collagenase on proE375-->A (a mutant of progelatinase A that cannot become active) because, in this instance, only an M(r) 68,000 species with L38 as the N-terminus was produced. The remaining propeptide amino acids to Y81 could be readily removed by added active gelatinase A, indicating that collagenase works by generating an intermediate that is susceptible to autolytic activation. Although relatively slow, the rate of activation could be increased approximately 10-fold by the addition of 100 micrograms/mL heparin. This binds to the C-terminal domain of collagenase and progelatinase A and presumably acts as a template that positions the reactants close to one another. Collagenase activated by trypsin retains 8 or 14 amino acids of its propeptide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981201     DOI: 10.1021/bi00252a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.

Authors:  Y Jo; J Yeon; H J Kim; S T Lee
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 2.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

3.  Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury.

Authors:  C A Herbert; M J Arthur; C Robinson
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Computational sequence analysis of matrix metalloproteinases.

Authors:  Q A Sang; D A Douglas
Journal:  J Protein Chem       Date:  1996-02

Review 5.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

Review 6.  Peripheral membrane associations of matrix metalloproteinases.

Authors:  Steven R Van Doren; Tara C Marcink; Rama K Koppisetti; Alexander Jurkevich; Yan G Fulcher
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-23       Impact factor: 4.739

Review 7.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

8.  Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.

Authors:  Z An; X Wang; N Willmott; S K Chander; S Tickle; A J Docherty; A Mountain; A T Millican; R Morphy; J R Porter; R O Epemolu; T Kubota; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

9.  Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation.

Authors:  Jae-Chang Jung; Paul X Wang; Guiyun Zhang; Yoichi Ezura; M Elizabeth Fini; David E Birk
Journal:  Cell Tissue Res       Date:  2009-02-17       Impact factor: 5.249

10.  Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans.

Authors:  Hyun-Jeong Ra; Susanna Harju-Baker; Fuming Zhang; Robert J Linhardt; Carole L Wilson; William C Parks
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.